A
NYSEHealthcareLoading…
Agilent Technologies, Inc. Common Stock
Sector: Healthcare•United States•Market Cap: $32.0B
Related News
Latest stories connected to A
- RS 75Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More24/7 Wall Street•Mar 11, 2026•Original source
- RS 75Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha•Mar 3, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 6.95B | 6.51B | 6.83B | 6.85B | 6.32B | 5.34B | 5.16B | 4.91B | 4.47B | 4.20B |
| Cost of Revenue | 3.31B | 2.98B | 3.37B | 3.13B | 2.91B | 2.50B | 2.36B | 2.23B | 2.06B | 2.00B |
| Gross Profit | 3.64B | 3.54B | 3.46B | 3.72B | 3.41B | 2.84B | 2.81B | 2.69B | 2.41B | 2.20B |
| Research and Development Expenses | 455.00M | 479.00M | 481.00M | 467.00M | 441.00M | 495.00M | 404.00M | 385.00M | 339.00M | 329.00M |
| General and Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling and Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 1.71B | 1.52B | 1.63B | 1.64B | 1.62B | 1.50B | 1.46B | 1.37B | 1.23B | 1.25B |
| Other Expenses | 0 | 50.00M | 0 | 0 | 0 | 0 | 0 | 17.00M | 0 | 0 |
| Operating Expenses | 2.16B | 2.05B | 2.12B | 2.10B | 2.06B | 1.99B | 1.86B | 1.78B | 1.57B | 1.58B |
| Cost and Expenses | 5.47B | 5.02B | 5.48B | 5.23B | 4.97B | 4.49B | 4.22B | 4.01B | 3.63B | 3.59B |
| Net Interest Income | -50.00M | -16.00M | -44.00M | -75.00M | -79.00M | -70.00M | -38.00M | -37.00M | -57.00M | -61.00M |
| Interest Income | 62.00M | 80.00M | 51.00M | 9.00M | 2.00M | 8.00M | 36.00M | 38.00M | 22.00M | 11.00M |
| Interest Expense | 112.00M | 96.00M | 95.00M | 84.00M | 81.00M | 78.00M | 74.00M | 75.00M | 79.00M | 72.00M |
| Depreciation and Amortization | 288.00M | 257.00M | 271.00M | 317.00M | 321.00M | 308.00M | 238.00M | 210.00M | 214.00M | 247.00M |
| EBITDA | 1.83B | 1.87B | 1.70B | 1.91B | 1.76B | 1.23B | 1.23B | 1.23B | 1.10B | 863.00M |
| EBIT | 1.55B | 1.62B | 1.43B | 1.59B | 1.44B | 920.00M | 993.00M | 1.02B | 882.00M | 616.00M |
| Non Operating Income Excluding Interest | -68.00M | -129.00M | -84.00M | 30.00M | -94.00M | -74.00M | -52.00M | -117.00M | -41.00M | -1.00M |
| Operating Income | 1.48B | 1.49B | 1.35B | 1.62B | 1.35B | 846.00M | 941.00M | 904.00M | 841.00M | 615.00M |
| Total Other Income Expenses Net | -44.00M | 33.00M | -11.00M | -114.00M | 13.00M | -4.00M | -22.00M | 42.00M | -38.00M | -71.00M |
| Income Before Tax | 1.44B | 1.52B | 1.34B | 1.50B | 1.36B | 842.00M | 919.00M | 946.00M | 803.00M | 544.00M |
| Income Tax Expense | 132.00M | 232.00M | 99.00M | 250.00M | 150.00M | 123.00M | -152.00M | 630.00M | 119.00M | 82.00M |
| Net Income From Continuing Operations | 1.30B | 1.29B | 1.24B | 1.25B | 1.21B | 719.00M | 1.07B | 316.00M | 684.00M | 462.00M |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 1.30B | 1.29B | 1.24B | 1.25B | 1.21B | 719.00M | 1.07B | 316.00M | 684.00M | 460.00M |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 4.59 | 4.44 | 4.22 | 4.19 | 3.98 | 2.33 | 3.41 | 0.98 | 2.12 | 1.42 |
| EPS Diluted | 4.57 | 4.43 | 4.19 | 4.18 | 3.94 | 2.3 | 3.37 | 0.97 | 2.1 | 1.4 |
| Weighted Average SHS Out | 283.00M | 290.00M | 294.00M | 299.00M | 304.00M | 309.00M | 314.00M | 321.00M | 322.00M | 326.00M |
| Weighted Average SHS Out Dil | 284.00M | 291.00M | 296.00M | 300.00M | 307.00M | 312.00M | 318.00M | 325.00M | 326.00M | 329.00M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.52 | 0.54 | 0.51 | 0.54 | 0.54 | 0.53 | 0.54 | 0.55 | 0.54 | 0.52 |
| R&D to Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 |
| SG&A to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Burden | 0.93 | 0.94 | 0.93 | 0.95 | 0.94 | 0.92 | 0.93 | 0.93 | 0.91 | 0.88 |
| EBIT Margin | 0.22 | 0.25 | 0.21 | 0.23 | 0.23 | 0.17 | 0.19 | 0.21 | 0.2 | 0.15 |
| EBITDA Margin | 0.26 | 0.29 | 0.25 | 0.28 | 0.28 | 0.23 | 0.24 | 0.25 | 0.25 | 0.21 |
| EBT per EBIT | 0.97 | 1.02 | 0.99 | 0.93 | 1.01 | 1 | 0.98 | 1.05 | 0.95 | 0.88 |
| Effective Tax Rate | 0.09 | 0.15 | 0.07 | 0.17 | 0.11 | 0.15 | -0.17 | 0.67 | 0.15 | 0.15 |
| Tax Burden | 0.91 | 0.85 | 0.93 | 0.83 | 0.89 | 0.85 | 1.17 | 0.33 | 0.85 | 0.85 |
| Cont. Operations Profit Margin | 0.19 | 0.2 | 0.18 | 0.18 | 0.19 | 0.13 | 0.21 | 0.06 | 0.15 | 0.11 |
| Bottom Line Profit Margin | 0.19 | 0.2 | 0.18 | 0.18 | 0.19 | 0.13 | 0.21 | 0.06 | 0.15 | 0.11 |
| Operating Cycle | 191.32 | 195.82 | 180.69 | 196.09 | 171.73 | 176 | 170.85 | 162.21 | 160.83 | 151.84 |
| Fwd PEG Ratio | 9.41 | 5.62 | 34.23 | 6.25 | 0.56 | -1.39 | 0.09 | -1.22 | 0.65 | 1.68 |
| Earnings Yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.05 | 0.02 | 0.03 | 0.03 |
| Income Quality | 3.59 | 1.36 | 1.43 | 1.05 | 1.23 | 1.28 | 0.95 | 3.44 | 1.3 | 1.72 |